Effect of Limicol on (LDL)-Cholesterol Levels in Moderate

Status Completed

Clinical Trial Summary

The purpose of this study is to validate the effectiveness of food supplement Limicol on reducing LDL-cholesterol in moderate hypercholesterolemic volunteers.

Clinical Trial Description

Cardiovascular disease (CVD), foremost among which ischemic heart disease and stroke, are the leading cause of mortality and morbidity in France. These diseases are multifactorial origin and even if it is not possible to act on risk markers such as age, sex, or heredity, risk factors like high cholesterol, smoking , hypertension, obesity, diabetes and physical inactivity, are the main target of prevention strategies.The dydlipidémies have a role in the formation of CVD in participating in the genesis of atherosclerosis. The cholesterol and LDL-cholesterol in particular is subject to oxidation process in plasma. The molecules of oxidized LDL-cholesterol, small and dense, easily penetrate the arterial endothelial wall and are greeted by macrophages. Following a succession of different processes including inflammation, atherosclerotic plaque is formed. The result is either an arteriopathy when the arterial lumen narrowing, or atherothrombosis in the event of plaque rupture. Given this pathophysiology, reduce blood lipids, including LDL-cholesterol and reducing oxidation and inflammation are interesting strategies in the context of cardiovascular prevention. Several scientific study showed that nutritional supplementation with some plant extracts such as artichokes, garlic, red yeast rice, or the sugar cane policosanol helps to reduce several cardiovascular risk factors including regulate concentrations of circulating lipids.

The objective of this study is to validate the effectiveness of Limicol, formulated with proven scientific data on the reduction of LDL-cholesterol in volunteers with moderate hypercholesterolaemia (LDL-cholesterol). ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01139398
Study type	Interventional
Source	Lescuyer Laboratory
Contact
Status	Completed
Phase	N/A
Start date	May 2010
Completion date	January 2012

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT06144008` - ESCAPE (Evaluating Surge Capacity And PrEparedness)
Completed	`NCT04594967` - The COPACC Study: Utilization, Health and Economic Evaluation of a Community-Based Primary Care Geriatric Hub at Whampoa
Completed	`NCT06453954` - Evaluating the Saving Babies Lives Care Bundle Version 2
Completed	`NCT05703503` - Mental Health and Healthcare in Adults With Intellectual Disabilities
Enrolling by invitation	`NCT01004276` - Increasing Smoking Cessation Counselling in Primary Care Using a Chronic Disease Management System	N/A
Recruiting	`NCT03946319` - Personalized, Transdiagnostic Approach to Preventative Mental Health	N/A
Active, not recruiting	`NCT05907174` - Siyakhana Peer: Evaluating a Peer Recovery Coach Model to Reduce Substance Use Stigma in South African HIV Care	N/A
Completed	`NCT03862261` - Integrating Pediatric TB Services Into Child Healthcare Services in Africa	N/A
Completed	`NCT00119548` - Improving HIV Screening With Nurse-Based Rapid Testing/Streamlined Counseling	N/A
Completed	`NCT03459664` - Evaluation of a Cross-sectional Coordinated, Severity Stepped, Evidence-based Care Model for Mental Disorders	N/A
Completed	`NCT01137305` - Soft Skills and Surgical Performance	N/A
Recruiting	`NCT05849753` - Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes
Recruiting	`NCT05026684` - Value For Veterans (V4V)	N/A
Withdrawn	`NCT03202745` - The Effect of Informative Letters on the Prescription and Receipt of Opioids	N/A
Completed	`NCT01304108` - Improving Venous Thromboembolism Prophylaxis	Phase 4
Completed	`NCT06450249` - Effects of the Humanitude® Care Methodology on Health Professionals' Perception
Completed	`NCT02625142` - Family-Centered Rounds Checklist Implementation	N/A
Completed	`NCT02665429` - A Quality Improvement Project to Investigate Individual Provider Variation in Opioid Prescribing From the Emergency Department	N/A
Completed	`NCT04176146` - Nudging Healthcare Organizations to Adopt New Care Delivery Practices	N/A
Completed	`NCT04722289` - The Together on Diabetes Intervention - a Realist Evaluation	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effect of Limicol on (LDL)-Cholesterol Levels in Moderate Hypercholesterolaemia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms